Michael Wainberg
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Michael Wainberg has a total of 168 co-authors. Here are the top co-authors by number of shared publications:
- Shreejoy J. Tripathy
The Krembil Centre for Neuroinformatics, Centre for Addiction & Mental Health, Toronto, ON, CA
10 shared publications - Nasa Sinnott-Armstrong
Herbold Computational Biology Program, Fred Hutchinson Cancer Center, Seattle, USA
5 shared publications - Keon Arbabi
Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Canada
4 shared publications - Manuel Antonio Rivas
Department of Biomedical Data Science, Stanford University, Stanford, CA, USA
4 shared publications - Caleb Ji
Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Canada
3 shared publications - Daniel Felsky
Centre for Addiction and Mental Health
3 shared publications
Latest Publications
- Open Access
- 14 November 2026
- Published by Springer Nature in npj Drug Discovery
- Vol. 3 (1) , 56
Benchmarking genome-wide association study causal gene prioritization for drug discovery
Drug discovery is costly, with billions spent on failed trials. Drugs with genetic support from genome-wide association studies (GWAS) have substantially greater odds of success, but how best to use GWAS to prioritize drug targets remains unclear. We evaluated the performance of GWAS causal gene prioritization methods from the Open Targets consortium by cross-referencing their predictions with drug trial outcomes for 445 diseases. We found that neither expression quantitative trait locus colocalization nor Open Targets’ locus-to-gene (L2G) score outperformed the simple nearest-gene method at prioritizing which genes would become approved drug targets. Our findings inform the use of genetic evidence in drug discovery.
- 14 November 2026
- Published by Springer Nature in npj Drug Discovery
- Vol. 3 (1) , 56
Open AccessBenchmarking genome-wide association study causal gene prioritization for drug discovery
Drug discovery is costly, with billions spent on failed trials. Drugs with genetic support from genome-wide association studies (GWAS) have substantially greater odds of success, but how best to use GWAS to prioritize drug targets remains unclear. We evaluated the performance of GWAS causal gene prioritization methods from the Open Targets consortium by cross-referencing their predictions with drug trial outcomes for 445 diseases. We found that neither expression quantitative trait locus colocalization nor Open Targets’ locus-to-gene (L2G) score outperformed the simple nearest-gene method at prioritizing which genes would become approved drug targets. Our findings inform the use of genetic evidence in drug discovery.
- Open Access
brisc: a multithreaded CPU toolkit for single-cell analysis
Single-cell RNA sequencing datasets have grown from tens of thousands of cells to tens of millions. At this scale, standard toolkits like Scanpy and Seurat need hours per analysis, hindering iterative exploration. We present brisc, the first end-to-end multithreaded CPU toolkit for single-cell analysis, spanning dimensionality reduction, integration, label transfer, clustering, embedding, differential expression and plotting. Unlike GPU-based counterparts, brisc strictly guarantees reproducibility: identical results between runs, regardless of thread count. Algorithmic innovations include a blocked inverted-file-index-based nearest-neighbors algorithm that makes 81–98% fewer errors than Scanpy and Seurat. On a 192-CPU node, brisc ran a standard workflow on 10 million cells in 3 minutes, 116× faster than Scanpy at under half its peak memory usage and 236× faster than Seurat with BPCells. On 96 CPUs, it matched the speed of rapids-singlecell on four H100 GPUs. brisc enables near-real-time, reproducible analysis of tens of millions of cells without specialized hardware.
Open Accessbrisc: a multithreaded CPU toolkit for single-cell analysis
Single-cell RNA sequencing datasets have grown from tens of thousands of cells to tens of millions. At this scale, standard toolkits like Scanpy and Seurat need hours per analysis, hindering iterative exploration. We present brisc, the first end-to-end multithreaded CPU toolkit for single-cell analysis, spanning dimensionality reduction, integration, label transfer, clustering, embedding, differential expression and plotting. Unlike GPU-based counterparts, brisc strictly guarantees reproducibility: identical results between runs, regardless of thread count. Algorithmic innovations include a blocked inverted-file-index-based nearest-neighbors algorithm that makes 81–98% fewer errors than Scanpy and Seurat. On a 192-CPU node, brisc ran a standard workflow on 10 million cells in 3 minutes, 116× faster than Scanpy at under half its peak memory usage and 236× faster than Seurat with BPCells. On 96 CPUs, it matched the speed of rapids-singlecell on four H100 GPUs. brisc enables near-real-time, reproducible analysis of tens of millions of cells without specialized hardware.
- 2 November 2026
- Published by Springer Nature in Nature Reviews Genetics
- p. 1-2
Genomics for chronic overlapping pain conditions
- 2 November 2026
- Published by Springer Nature in Nature Reviews Genetics
- p. 1-2
Genomics for chronic overlapping pain conditions
- Open Access
- 14 October 2026
- Published by Springer Nature in Nature
- Vol. 659 (8141) , 827-837
A microexon regulatory code reveals autism-linked genetic variation
Neuronal microexons are a highly conserved class of alternative splicing events enriched in genes with critical functions in nervous system biology 1,2 . Microexon splicing is often disrupted in the brains of autistic individuals, and mice with microexon deficiencies display autism-like phenotypes 1,3,4 . However, the full landscape of microexons is not known, and the impact of genetic variation on these exons has not been systematically investigated. Here, through extensive transcriptome profiling, we detect hundreds of new microexons, including many with neuronal subtype-specific splicing patterns, and others that activate nonsense-mediated mRNA decay. Using machine learning, we define a sequence code predictive of neuronally spliced microexons and use this to identify critical regulatory elements surrounding the expanded microexon repertoire. This code further reveals genomic variants predicted to alter microexon splicing in individuals affected by autism, with rare variants having the strongest estimated impact. These variants are mostly detected in idiopathic individuals and are associated with autism status. They also converge on synaptic and other autism-linked genes, as well as genes not previously linked to autism. Our results collectively define an expanded repertoire of microexons, delineate their regulatory code, and pinpoint variants predicted to affect their splicing, with implications for the disruption of functions central to neuronal biology and brain disorders.
- 14 October 2026
- Published by Springer Nature in Nature
- Vol. 659 (8141) , 827-837
Open AccessA microexon regulatory code reveals autism-linked genetic variation
Neuronal microexons are a highly conserved class of alternative splicing events enriched in genes with critical functions in nervous system biology 1,2 . Microexon splicing is often disrupted in the brains of autistic individuals, and mice with microexon deficiencies display autism-like phenotypes 1,3,4 . However, the full landscape of microexons is not known, and the impact of genetic variation on these exons has not been systematically investigated. Here, through extensive transcriptome profiling, we detect hundreds of new microexons, including many with neuronal subtype-specific splicing patterns, and others that activate nonsense-mediated mRNA decay. Using machine learning, we define a sequence code predictive of neuronally spliced microexons and use this to identify critical regulatory elements surrounding the expanded microexon repertoire. This code further reveals genomic variants predicted to alter microexon splicing in individuals affected by autism, with rare variants having the strongest estimated impact. These variants are mostly detected in idiopathic individuals and are associated with autism status. They also converge on synaptic and other autism-linked genes, as well as genes not previously linked to autism. Our results collectively define an expanded repertoire of microexons, delineate their regulatory code, and pinpoint variants predicted to affect their splicing, with implications for the disruption of functions central to neuronal biology and brain disorders.
- Top Cited PapersOpen Access
- 28 July 2026
- Published by Springer Nature in Nature Medicine
- Vol. 32 (8) , 3060-3070
The genetic architecture of fibromyalgia across 2.5 million individuals
Fibromyalgia is a common and debilitating chronic pain syndrome of poorly understood etiology. Here we conduct a multi-ancestry genome-wide association study meta-analysis across 2,563,755 individuals (54,629 cases and 2,509,126 controls) from 11 cohorts, identifying 26 risk loci for fibromyalgia. The strongest association was with a coding variant in HTT , the causal gene for Huntington’s disease. Gene prioritization implicated the HTT regulator GPR52 , as well as diverse genes with neural roles, including DCC , DRD2 / NCAM1 , MDGA2 and CELF4 . Fibromyalgia heritability was exclusively enriched within brain tissues and neural cell types. Fibromyalgia showed strong, positive genetic correlation with a wide range of chronic pain, psychiatric and somatic disorders, including genetic correlations above 0.7 with low back pain, post-traumatic stress disorder and irritable bowel syndrome. Despite large sex differences in fibromyalgia prevalence, the genetic architecture of fibromyalgia was nearly identical between males and females. This study provides robust genetic evidence defining fibromyalgia as a central nervous system disorder, thereby establishing a biological framework for its complex pathophysiology and extensive clinical comorbidities.
- 28 July 2026
- Published by Springer Nature in Nature Medicine
- Vol. 32 (8) , 3060-3070
Top Cited PapersOpen AccessThe genetic architecture of fibromyalgia across 2.5 million individuals
Fibromyalgia is a common and debilitating chronic pain syndrome of poorly understood etiology. Here we conduct a multi-ancestry genome-wide association study meta-analysis across 2,563,755 individuals (54,629 cases and 2,509,126 controls) from 11 cohorts, identifying 26 risk loci for fibromyalgia. The strongest association was with a coding variant in HTT , the causal gene for Huntington’s disease. Gene prioritization implicated the HTT regulator GPR52 , as well as diverse genes with neural roles, including DCC , DRD2 / NCAM1 , MDGA2 and CELF4 . Fibromyalgia heritability was exclusively enriched within brain tissues and neural cell types. Fibromyalgia showed strong, positive genetic correlation with a wide range of chronic pain, psychiatric and somatic disorders, including genetic correlations above 0.7 with low back pain, post-traumatic stress disorder and irritable bowel syndrome. Despite large sex differences in fibromyalgia prevalence, the genetic architecture of fibromyalgia was nearly identical between males and females. This study provides robust genetic evidence defining fibromyalgia as a central nervous system disorder, thereby establishing a biological framework for its complex pathophysiology and extensive clinical comorbidities.
- Open Access
The genetic architecture of fibromyalgia across 2.5 million individuals
Fibromyalgia is a common and debilitating chronic pain syndrome of poorly understood etiology. Here, we conduct a multi-ancestry genome-wide association study meta-analysis across 2,563,755 individuals (54,629 cases and 2,509,126 controls) from 11 cohorts, identifying the first 26 risk loci for fibromyalgia. The strongest association was with a coding variant in HTT , the causal gene for Huntington’s disease. Gene prioritization implicated the HTT regulator GPR52 , as well as diverse genes with neural roles, including CAMKV , DCC , DRD2 / NCAM1 , MDGA2 , and CELF4 . Fibromyalgia heritability was exclusively enriched within brain tissues and neural cell types. Fibromyalgia showed strong, positive genetic correlation with a wide range of chronic pain, psychiatric, and somatic disorders, including genetic correlations above 0.7 with low back pain, post-traumatic stress disorder and irritable bowel syndrome. Despite large sex differences in fibromyalgia prevalence, the genetic architecture of fibromyalgia was nearly identical between males and females. This work provides the first robust genetic evidence defining fibromyalgia as a central nervous system disorder, thereby establishing a biological framework for its complex pathophysiology and extensive clinical comorbidities.
Open AccessThe genetic architecture of fibromyalgia across 2.5 million individuals
Fibromyalgia is a common and debilitating chronic pain syndrome of poorly understood etiology. Here, we conduct a multi-ancestry genome-wide association study meta-analysis across 2,563,755 individuals (54,629 cases and 2,509,126 controls) from 11 cohorts, identifying the first 26 risk loci for fibromyalgia. The strongest association was with a coding variant in HTT , the causal gene for Huntington’s disease. Gene prioritization implicated the HTT regulator GPR52 , as well as diverse genes with neural roles, including CAMKV , DCC , DRD2 / NCAM1 , MDGA2 , and CELF4 . Fibromyalgia heritability was exclusively enriched within brain tissues and neural cell types. Fibromyalgia showed strong, positive genetic correlation with a wide range of chronic pain, psychiatric, and somatic disorders, including genetic correlations above 0.7 with low back pain, post-traumatic stress disorder and irritable bowel syndrome. Despite large sex differences in fibromyalgia prevalence, the genetic architecture of fibromyalgia was nearly identical between males and females. This work provides the first robust genetic evidence defining fibromyalgia as a central nervous system disorder, thereby establishing a biological framework for its complex pathophysiology and extensive clinical comorbidities.
- Top Cited PapersOpen Access
- 4 March 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-20
Genetic architecture of the structural connectome
Myelinated axons form long-range connections that enable rapid communication between distant brain regions, but how genetics governs the strength and organization of these connections remains unclear. We perform genome-wide association studies of 206 structural connectivity measures derived from diffusion magnetic resonance imaging tractography of 26,333 UK Biobank participants, each representing the density of myelinated connections within or between a pair of cortical networks, subcortical structures or cortical hemispheres. We identify 30 independent genome-wide significant variants after Bonferroni correction for the number of measures studied (126 variants at nominal genome-wide significance) implicating genes involved in myelination (SEMA3A), neurite elongation and guidance (NUAK1, STRN, DPYSL2, EPHA3, SEMA3A, HGF, SHTN1), neural cell proliferation and differentiation (GMNC, CELF4, HGF), neuronal migration (CCDC88C), cytoskeletal organization (CTTNBP2, MAPT, DAAM1, MYO16, PLEC), and brain metal transport (SLC39A8). These variants have four broad patterns of spatial association with structural connectivity: some have disproportionately strong associations with corticothalamic connectivity, interhemispheric connectivity, or both, while others are more spatially diffuse. Structural connectivity measures are highly polygenic, with a median of 9.1 percent of common variants estimated to have non-zero effects on each measure, and exhibited signatures of negative selection. Structural connectivity measures have significant genetic correlations with a variety of neuropsychiatric and cognitive traits, indicating that connectivity-altering variants tend to influence brain health and cognitive function. Heritability is enriched in regions with increased chromatin accessibility in adult oligodendrocytes (as well as microglia, inhibitory neurons and astrocytes) and multiple fetal cell types, suggesting that genetic control of structural connectivity is partially mediated by effects on myelination and early brain development. Our results indicate pervasive, pleiotropic, and spatially structured genetic control of white-matter structural connectivity via diverse neurodevelopmental pathways, and support the relevance of this genetic control to healthy brain function.
- 4 March 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-20
Top Cited PapersOpen AccessGenetic architecture of the structural connectome
Myelinated axons form long-range connections that enable rapid communication between distant brain regions, but how genetics governs the strength and organization of these connections remains unclear. We perform genome-wide association studies of 206 structural connectivity measures derived from diffusion magnetic resonance imaging tractography of 26,333 UK Biobank participants, each representing the density of myelinated connections within or between a pair of cortical networks, subcortical structures or cortical hemispheres. We identify 30 independent genome-wide significant variants after Bonferroni correction for the number of measures studied (126 variants at nominal genome-wide significance) implicating genes involved in myelination (SEMA3A), neurite elongation and guidance (NUAK1, STRN, DPYSL2, EPHA3, SEMA3A, HGF, SHTN1), neural cell proliferation and differentiation (GMNC, CELF4, HGF), neuronal migration (CCDC88C), cytoskeletal organization (CTTNBP2, MAPT, DAAM1, MYO16, PLEC), and brain metal transport (SLC39A8). These variants have four broad patterns of spatial association with structural connectivity: some have disproportionately strong associations with corticothalamic connectivity, interhemispheric connectivity, or both, while others are more spatially diffuse. Structural connectivity measures are highly polygenic, with a median of 9.1 percent of common variants estimated to have non-zero effects on each measure, and exhibited signatures of negative selection. Structural connectivity measures have significant genetic correlations with a variety of neuropsychiatric and cognitive traits, indicating that connectivity-altering variants tend to influence brain health and cognitive function. Heritability is enriched in regions with increased chromatin accessibility in adult oligodendrocytes (as well as microglia, inhibitory neurons and astrocytes) and multiple fetal cell types, suggesting that genetic control of structural connectivity is partially mediated by effects on myelination and early brain development. Our results indicate pervasive, pleiotropic, and spatially structured genetic control of white-matter structural connectivity via diverse neurodevelopmental pathways, and support the relevance of this genetic control to healthy brain function.
- Open Access
- 10 April 2023
- Published by Elsevier in Biological Psychiatry
- Vol. 93 (9) , S282
464. Brain Transcriptomic Signatures of Race in Schizophrenia (SCZ) and Controls
- 10 April 2023
- Published by Elsevier in Biological Psychiatry
- Vol. 93 (9) , S282
Open Access464. Brain Transcriptomic Signatures of Race in Schizophrenia (SCZ) and Controls
- 18 November 2022
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 157, 152-161
Association analyses of the autosomal genome and mitochondrial DNA with accelerometry-derived sleep parameters in depressed UK biobank subjects
- 18 November 2022
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 157, 152-161
Association analyses of the autosomal genome and mitochondrial DNA with accelerometry-derived sleep parameters in depressed UK biobank subjects
- Open Access
- 1 June 2022
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 119 (23)
Multiscale neural signatures of major depressive, anxiety, and stress-related disorders
Significance: Major depressive, anxiety, and stress-related disorders are highly comorbid and may affect similar neurocircuitry and cognitive processes. However, the neurocircuitry underlying shared dimensions of cognitive impairment is unclear and holds the promise of reimagining psychiatric nosology. Here we leverage population imaging data ( n = 27,132) to show that while major depressive and anxiety disorders share functional and structural neural signatures, stress-related disorders are distinct from these two conditions. We report that better cognitive function is associated with lower connectivity of specific nodes of the default mode and frontoparietal networks. These findings provide population benchmarks for brain–cognition associations in healthy participants and those with lifetime major depressive and anxiety disorders, advancing our understanding of intrinsic brain networks underlying cognitive dysfunction.
- 1 June 2022
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 119 (23)
Open AccessMultiscale neural signatures of major depressive, anxiety, and stress-related disorders
Significance: Major depressive, anxiety, and stress-related disorders are highly comorbid and may affect similar neurocircuitry and cognitive processes. However, the neurocircuitry underlying shared dimensions of cognitive impairment is unclear and holds the promise of reimagining psychiatric nosology. Here we leverage population imaging data ( n = 27,132) to show that while major depressive and anxiety disorders share functional and structural neural signatures, stress-related disorders are distinct from these two conditions. We report that better cognitive function is associated with lower connectivity of specific nodes of the default mode and frontoparietal networks. These findings provide population benchmarks for brain–cognition associations in healthy participants and those with lifetime major depressive and anxiety disorders, advancing our understanding of intrinsic brain networks underlying cognitive dysfunction.